News Opinion Conversations in Cardiology Conversations in Cardiology: Bridging Antithrombotic Therapy Between PCI & CABG June 03, 2013
News Conference News ACC 2013 ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting L.A. McKeown March 14, 2013
News Conference News ACC 2013 Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients Yael L. Maxwell March 09, 2013
News Daily News Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients L.A. McKeown December 05, 2012
News Daily News Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI L.A. McKeown December 05, 2012
News Daily News Universal Definition of MI Shifts Advantage Toward Cangrelor in PCI Caitlin E. Cox March 20, 2012
News Daily News La Definición Universal de IM se Posiciona en Favor del Cangrelor en las PCI Caitlin E. Cox March 20, 2012
Presentation Reduced Immediate Ischemic Events with Cangrelor in PCI: Pooled Analysis of the CHAMPION Trials Using the Universal Definition of MI Presenter: 35236|Harvey White March 16, 2012
Presentation Menores Episodios Isquémicos Inmediatos con el Cangrelor en las PCI: Análisis Conjunto de los Ensayos Champion usando la Definición Universal de IM Presenter: Harvey D. White March 16, 2012
Presentation Puenteando la Terapia Antiplaquetaria con Cangrelor en Pacientes que se someten a Cirugía Cardíaca Presenter: Dominick J. Angiolillo January 16, 2012
Presentation Bridging Antiplatelet Therapy with Cangrelor in Patients Undergoing Cardiac Surgery Presenter: Dominick J. Angiolillo January 16, 2012
News Conference News BRIDGE: Cangrelor Provides Effective Maintenance of Platelet Inhibition Without Major Bleeding November 09, 2011
News Industry News Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT November 08, 2011
News Industry News Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery November 08, 2011
CME A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI